SynthesisJournal of the National Cancer Institute2026

Optimizing oncology drug development: systematic review of 22 years of myeloma randomized controlled trials.

Maria Mainou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.